Select Page
Hero
Hero
Hero
Hero
Hero
Hero
Hero
Hero

90% of people with plaque psoriasis still rely on topicals.

And they’re frustrated with topical options that are restricted to certain areas, don’t work, or aren’t safe long-term.

They’re tired of seeing advertisements that characterize some other life they should be living.

The Skincredible™ campaign focuses on what truly matters to these patients—their skin.

With ZORYVE, patients have a powerful AND safe option to help clear symptoms.

Finally, patients with plaque psoriasis can simply envision themselves with beautiful skin.

Incredible!

:30 Online Video

Facebook_Post_Desktop_1b4
Facebook_Post_Desktop_1b1
Facebook_Post_Desktop_1b2
Facebook_Post_Desktop_1b3
Facebook_Post_Desktop_34
Facebook_Post_Desktop_31
Facebook_Post_Desktop_32
Facebook_Post_Desktop_33
Facebook_Post_Desktop_24
Facebook_Post_Desktop_21
Facebook_Post_Desktop_22
Facebook_Post_Desktop_23

Social

The Skincredible campaign drove 320,000 site visitors to Zoryve.com from August–November, 70% higher than the Google Analytics Pharma Industry benchmark.

Website

Patient Brochure

The number of patients spontaneously mentioning ZORYVE on an unaided basis when asked to name prescription Plaque Psoriasis treatments which come to mind is comparable to established brands such as Enbrel, Skyrizi, and Dovonex. Conversely, other recently launched treatment brands such as VTAMA and SOTYKTU have relatively no unaided awareness.

In-Office